INTRACOASTAL CAPITAL, LLC → Bluejay Diagnostics, Inc. BJDX

Stake: — Shares: — Class: Common stock, par value $0.0001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

144,402 shares short · +0.5% vs prior

Other 13D/G Filings on Bluejay Diagnostics, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-02	SCHEDULE 13D/A	NORTHSTRIVE FUND II LP	—	0	view →
2026-06-02	SCHEDULE 13D/A	Braeden Lichti	—	0	view →

Other Filings by INTRACOASTAL CAPITAL, LLC

Filed	Form	Issuer	Stake	Shares
2026-09-23	SCHEDULE 13G	SCWorx Corp.	—	—	view →
2026-08-27	SCHEDULE 13G	NFT Limited	—	—	view →
2026-08-20	SCHEDULE 13G	GAXOS.AI INC.	—	—	view →
2026-08-18	SCHEDULE 13G	Silexion Therapeutics Corp	—	—	view →
2026-07-21	SCHEDULE 13G	SOBR Safe, Inc.	—	—	view →
2026-07-06	SCHEDULE 13G	Tenon Medical, Inc. TNONW	—	—	view →
2026-05-27	SCHEDULE 13G	AIM ImmunoTech Inc. AIM	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →